ArticleScientific reports2021

Implementing a method for engineering multivalency to substantially enhance binding of clinical trial anti-SARS-CoV-2 antibodies to wildtype spike and variants of concern proteins.

Adam Leach et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.